Product Description

🔹 Product Overview
Emzumab 150 mg Injection is a prescription biological medicine containing Omalizumab 150 mg. Omalizumab is a monoclonal antibody that targets immunoglobulin E (IgE), an antibody involved in allergic and inflammatory responses.
Emzumab 150 mg is primarily used under medical supervision for the management of certain allergic conditions, including moderate to severe allergic asthma. Depending on the patient's condition and local approved indications, omalizumab may also be used for chronic spontaneous urticaria (chronic hives) and chronic rhinosinusitis with nasal polyps.
Emzumab is a prescription injection and should be administered according to the treatment plan established by a qualified healthcare professional.

🔹 Key Uses
Emzumab 150 mg Injection may be prescribed for:
Moderate to severe allergic asthma
Chronic spontaneous urticaria (chronic hives)
Chronic rhinosinusitis with nasal polyps, where approved and clinically appropriate
Reducing symptoms associated with IgE-mediated allergic disease
Long-term control of eligible allergic conditions
The exact indication depends on the patient's diagnosis, age, clinical history and applicable prescribing guidelines.
Important: Emzumab is a maintenance/control treatment and is not intended to treat a sudden asthma attack. Patients with asthma should continue to keep their prescribed rescue medication available.

🔹 Composition
Active Ingredient: Omalizumab 150 mg
Brand: Emzumab
Strength: 150 mg
Drug Class: Monoclonal antibody
Dosage Form: Injection
Route: As directed by a healthcare professional
Manufacturer/Marketer: Cipla Ltd.

🔹 How Emzumab 150 mg Works
Emzumab contains omalizumab, a monoclonal antibody that targets immunoglobulin E (IgE).
IgE plays an important role in allergic reactions. Omalizumab binds to free IgE and reduces its availability for triggering allergic pathways. This can help decrease allergic inflammation and reduce symptoms in appropriately selected patients.
By targeting the IgE pathway, omalizumab can help control certain allergic diseases rather than simply providing temporary relief of individual symptoms.

🔹 Key Benefits
Contains Omalizumab 150 mg
Targeted monoclonal-antibody treatment
Helps control certain IgE-mediated allergic conditions
Used as part of long-term management for eligible patients
May help reduce symptoms and disease-related exacerbations in appropriately selected patients
Used under prescription and medical supervision
Available as a refrigerated injectable medicine

🔹 Dosage and Administration
The dosage of Emzumab is not the same for every patient.
For allergic asthma, the omalizumab dose and frequency are determined using factors such as the patient's body weight and IgE level, along with the clinical indication.
For chronic spontaneous urticaria and other approved indications, dosing may follow different criteria.
Therefore, patients should not determine the dose themselves based solely on the 150 mg strength.
Emzumab should be administered exactly as prescribed by the treating physician. Do not increase, decrease, skip or repeat doses without medical advice.

🔹 How Emzumab 150 mg Is Administered
Emzumab is an injectable prescription medicine. Administration should follow the product's approved instructions and the healthcare professional's guidance.
Depending on the specific presentation and treatment plan, administration may be performed by a healthcare professional or, where appropriate and specifically instructed, by a trained patient/caregiver.
Do not attempt to prepare or inject the medicine without appropriate training and medical instructions.

🔹 Possible Side Effects
Like other biological medicines, Emzumab may cause side effects.
Commonly reported effects can include:
Injection-site reactions
Joint pain
Headache
Dizziness
Fatigue
Abdominal discomfort or upper abdominal pain
Nasopharyngitis/common-cold symptoms
Itching or skin reactions
Ear pain
Many side effects may be mild and temporary, but persistent or worsening symptoms should be discussed with a doctor.

🔹 Serious Allergic Reaction – Important Warning
Omalizumab can rarely cause serious hypersensitivity reactions, including anaphylaxis.
Seek immediate medical attention if symptoms such as the following occur after administration:
Difficulty breathing
Swelling of the face, lips, tongue or throat
Severe dizziness or fainting
Widespread hives
Sudden difficulty swallowing
Severe allergic symptoms
Patients should follow their healthcare provider's instructions regarding observation and emergency management after receiving the injection.

🔹 Precautions
Before starting Emzumab 150 mg, inform your doctor if you have:
A history of serious allergic reactions
Liver or kidney problems
Autoimmune disease
Parasitic infections or a risk of parasitic infection
Other significant medical conditions
A history of severe reactions to injectable medicines